The Department of Veterans Affairs (VA) Prosthetics Sensory Aid Service (PSAS) requires the acquisition biologics and biological Implants. VHA manages the United States’ largest integrated healthcare system. Veterans’ healthcare is separated geographically into 21 Veterans Integrated Services Networks (VISNs) with approximately 168 VA Medical Centers (VAMCs), 1,053 outpatient sites , and various other Federal facilities to include Community Living Centers (CLCs), Vet Centers and Domiciliary. Together these health care facilities, and the more than 53,000 independent licensed health care practitioners who work within them, provide comprehensive care to about 9.3 million enrolled Veterans.
VHA PSAS have a need for biologics and biological implants. The objective of this procurement is to ensure availability and consistency of products for nationwide usage and to obtain volume-based, standardized pricing by establishing enterprise-wide IDIQ contracts. The Government desires to continue the practice of reducing costs by standardizing the ordering of products and sources of supply while, simultaneously, balancing clinician considerations for obtaining quality products.
The commodities to be acquired are various types of biologics and biological implants, which include any human cell, tissue, or cellular or tissue-based product or animal product inserted or grafted into the body for prosthetic, therapeutic purposes. The goal is for the implant to restore or replace a body function, or restore appearance.
These biologics and biological implants are to be used in various surgeries, treatments, and medical procedures to treat, prevent, or diagnose diseases. Biologics and biologic implants will consist of allograft and xenograft tissue. Allografts are bone and soft tissue grafts taken from human cadavers of genetically non-identical member of the same species. Most human tissue and organ transplants are allografts. Xenografts are bone and soft-tissue grafts taken from animals, typically pigs and cows.